Gujarat Inject (Kerala) Ltd has revised the record date for its proposed stock split to Wednesday, July 8, 2026, superseding the earlier schedule of July 2. The sub-division of equity shares will reduce the face value from ₹10 to Re.1 per share, aiming to enhance liquidity by increasing the number of shares available for trading. The company confirmed that the remaining terms and conditions of the corporate action remain unchanged.

The board of directors had previously approved the restructuring, which shareholders authorized via an Ordinary Resolution at an Extra-Ordinary General Meeting. The split ratio is 1-for-10, meaning every single existing equity share of ₹10 will be divided into 10 equity shares of Re.1 each. The intimation regarding the revised schedule was submitted to BSE Limited pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Details of the Stock Split

The following table outlines the specific changes to the company's equity share structure:

Financial Highlights and Strategic Shift

The corporate action coincides with robust financial performance for the fiscal period ended March 2026. Net sales for the quarter ended March 2026 rose 624.06% year-on-year to ₹30.70 Crore, while net profit for the quarter surged 2,242.86% to ₹1.64 Crore. For the full year ended March 2026, revenue increased 90.66% to ₹36.32 Crore, and net profit grew 77.45% to ₹1.81 Crore.

Operational expansion includes securing solar orders worth over ₹21.6 Crore, such as a ₹14.49 Crore contract from Deon Energy Limited and a ₹1.07 Crore order from Ottire Lifestyle Private Limited. The company is also proposing a rebranding to Regenova Renewtech Limited to align with its focus on clean energy solutions.

Manmeetkaur Harshdeepsingh Bhatia, Company Secretary & Compliance Officer, signed the regulatory filing confirming the revised schedule.

Source: https://lodr-files.dhan.co/lodr-inputs/Company/INE659F01014/718e360c-c425-4588-8cc3-9a08bc40a021.pdf

Gujarat Inject (Kerala) Ltd announced the demise of Mr. Deepak Diwan Bachwani, who served as Whole-Time Director, Chief Financial Officer, and Chairman, on 23 June 2026. The company informed the exchanges that his passing necessitates changes to its leadership structure, with Mr. Bachwani ceasing to be the Whole-Time Director and Chief Financial Officer effective immediately. The Board of Directors expressed their deepest condolences to the bereaved family, acknowledging his invaluable guidance and contribution during his tenure.

The disclosure was made to BSE Limited pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company also provided details as required under SEBI Circular No. CIRCULARHO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated 30th January 2026.

The regulatory filing outlined the specifics of the cessation of office. The reason for the change was recorded as death, with the date of cessation noted as 23 June 2026. The document confirmed that the departing director did not hold directorships in any other listed entities.

Key Disclosures